Norman Breslow

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. pmc Secondary malignant neoplasms after Wilms tumor: an international collaborative study
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, WA 98195 7232, USA
    Int J Cancer 127:657-66. 2010
  2. pmc Using the whole cohort in the analysis of case-cohort data
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, Washington 98195 7232, USA
    Am J Epidemiol 169:1398-405. 2009
  3. ncbi request reprint Are statistical contributions to medicine undervalued?
    Norman E Breslow
    Department of Biostatistics, Box 357232, University of Washington, Seattle, Washington 98195 7232, USA
    Biometrics 59:1-8. 2003
  4. pmc End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System
    Norman E Breslow
    Department of Biostatistics, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington 98195 7232, USA
    J Urol 174:1972-5. 2005
  5. pmc Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, Washington 98195 7232, USA
    Pediatr Blood Cancer 47:260-7. 2006
  6. ncbi request reprint Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group
    Norman E Breslow
    Department of Biostatistics, Box 357232, University of Washington, Seattle, WA 98195 7232, USA
    J Clin Oncol 21:4579-85. 2003
  7. ncbi request reprint Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle 98195 7232, USA
    Cancer 101:1072-80. 2004
  8. ncbi request reprint Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
    Richard A Jensen
    Department of Biostatistics, University of Washington, Seattle, WA, USA
    J Diabetes Complications 21:205-13. 2007
  9. pmc Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, WA 98195 7232, USA
    Int J Radiat Oncol Biol Phys 65:203-9. 2006
  10. pmc Early and late mortality after diagnosis of wilms tumor
    Cecilia A Cotton
    Department of Biostatistics, University of Washington, Mail Stop 357232, Seattle, WA 98195 7232, USA
    J Clin Oncol 27:1304-9. 2009

Research Grants

Detail Information

Publications28

  1. pmc Secondary malignant neoplasms after Wilms tumor: an international collaborative study
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, WA 98195 7232, USA
    Int J Cancer 127:657-66. 2010
    ..003). These trends may reflect the decreasing use of radiation therapy and increasing intensity of chemotherapy in modern protocols for treatment of WT...
  2. pmc Using the whole cohort in the analysis of case-cohort data
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, Washington 98195 7232, USA
    Am J Epidemiol 169:1398-405. 2009
    ..Epidemiologists are encouraged to consider use of these methods to enhance the accuracy of results reported from case-cohort analyses...
  3. ncbi request reprint Are statistical contributions to medicine undervalued?
    Norman E Breslow
    Department of Biostatistics, Box 357232, University of Washington, Seattle, Washington 98195 7232, USA
    Biometrics 59:1-8. 2003
    ....
  4. pmc End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System
    Norman E Breslow
    Department of Biostatistics, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington 98195 7232, USA
    J Urol 174:1972-5. 2005
    ....
  5. pmc Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, Washington 98195 7232, USA
    Pediatr Blood Cancer 47:260-7. 2006
    ..The National Wilms Tumor Study (NWTS) constitutes a unique resource for study of clinical, pathologic, and epidemiologic features of Wilms tumor (WT)...
  6. ncbi request reprint Characteristics and outcomes of children with the Wilms tumor-Aniridia syndrome: a report from the National Wilms Tumor Study Group
    Norman E Breslow
    Department of Biostatistics, Box 357232, University of Washington, Seattle, WA 98195 7232, USA
    J Clin Oncol 21:4579-85. 2003
    ..We compared demographics, disease characteristics, and treatment outcomes in a large cohort of WT patients who did or did not have the WAGR syndrome...
  7. ncbi request reprint Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle 98195 7232, USA
    Cancer 101:1072-80. 2004
    ..Double-agent chemotherapy was retained for patients with Stage II disease. In this study, the authors reevaluated the efficacy of DOX using extended follow-up and additional patients...
  8. ncbi request reprint Multiple factors affect the loss of measurable C-peptide over 6 years in newly diagnosed 15- to 35-year-old diabetic subjects
    Richard A Jensen
    Department of Biostatistics, University of Washington, Seattle, WA, USA
    J Diabetes Complications 21:205-13. 2007
    ..The aim of this study is to identify risk factors for the loss of measurable plasma C-peptide in newly diagnosed 15- to 35-year-old diabetic subjects...
  9. pmc Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4
    Norman E Breslow
    Department of Biostatistics, University of Washington, Seattle, WA 98195 7232, USA
    Int J Radiat Oncol Biol Phys 65:203-9. 2006
    ..To determine whether radiation therapy (RT) of patients with Wilms tumor of favorable histology prevented flank recurrence and thereby improved the survival outcomes...
  10. pmc Early and late mortality after diagnosis of wilms tumor
    Cecilia A Cotton
    Department of Biostatistics, University of Washington, Mail Stop 357232, Seattle, WA 98195 7232, USA
    J Clin Oncol 27:1304-9. 2009
    ..To assess rates and causes of mortality in patients with Wilms tumor (WT)...
  11. ncbi request reprint A profile of Norman Breslow
    Polly Feigl
    Department of Biostatistics, University of Washington, F 600 Health Sciences Building, Campus Mail Stop 357232, Seattle, WA 98195 7232, USA
    Lifetime Data Anal 13:439-41. 2007
  12. ncbi request reprint Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group
    James H Feusner
    Department of Hematology Oncology, Children s Hospital and Research Center Oakland, Oakland, California, USA
    Pediatr Blood Cancer 50:242-5. 2008
    ....
  13. ncbi request reprint Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study
    Jeffrey S Dome
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    J Clin Oncol 24:2352-8. 2006
    ..An objective of the fifth National Wilms' Tumor Study (NWTS-5) was to evaluate the efficacy of treatment regimens for anaplastic histology Wilms' tumor (AH)...
  14. ncbi request reprint Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group
    Daniel M Green
    Department of Pediatrics, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
    Pediatr Blood Cancer 48:493-9. 2007
    ..A uniform approach to the treatment of patients with relapse was employed...
  15. ncbi request reprint Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group
    Marcio Malogolowkin
    Department of Pediatrics, Children s Hospital Los Angeles, Los Angeles, California, USA
    Pediatr Blood Cancer 50:236-41. 2008
    ....
  16. ncbi request reprint Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor
    Gail E Tomlinson
    Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 8593, USA
    J Clin Oncol 23:7641-5. 2005
    ..The objective of this study is to determine prognostic factors in rhabdoid tumor of the kidney (RTK), including both demographic and treatment variables...
  17. ncbi request reprint Correction to "Congestive heart failure after treatment for Wilms' tumor"
    Daniel M Green
    J Clin Oncol 21:2447-8. 2003
  18. ncbi request reprint Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group
    John A Kalapurakal
    Robert H Lurie Cancer Center, Northwestern University, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 57:495-9. 2003
    ....
  19. ncbi request reprint Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group
    Nita L Seibel
    Department of Hematology Oncology, Children s National Medical Center, 111 Michigan Avenue NW, Washington, DC 20010, USA
    J Clin Oncol 22:468-73. 2004
    ....
  20. ncbi request reprint Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study
    John A Kalapurakal
    Department of Radiation Oncology, Northwestern University, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 58:1364-8. 2004
    ..This report describes the pregnancy outcomes among 7 survivors of childhood Wilms tumor, who were treated on one of the National Wilms Tumor Studies (NWTS) with radiation therapy (RT) portals that extended beyond the flank...
  21. ncbi request reprint Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group
    Paul E Grundy
    Department of Pediatrics, Roswell Park Cancer Institute, Taipei
    J Clin Oncol 23:7312-21. 2005
    ..To determine if tumor-specific loss of heterozygosity (LOH) for chromosomes 1p or 16q is associated with a poorer prognosis for children with favorable-histology (FH) Wilms tumor entered on the fifth National Wilms Tumor Study (NWTS-5)...
  22. ncbi request reprint High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor
    Jeffrey S Dome
    Department of Hematology Oncology, St Jude Children s Research Hospital, Memphis, TN 38105, USA
    J Clin Oncol 23:9138-45. 2005
    ..The prognostic significance of telomerase expression level in primary tumor samples was assessed...
  23. pmc Household pesticides and the risk of Wilms tumor
    Maureen A Cooney
    Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina 27599 7435, USA
    Environ Health Perspect 115:134-7. 2007
    ..Previous epidemiologic studies have suggested that exposure to pesticides in utero and during early childhood may increase the risk for development of childhood cancer, including Wilms tumor, a childhood kidney tumor...
  24. ncbi request reprint Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors
    Michal A Miller
    Department of Surgery, University of Iowa, Iowa City, Iowa 52242, USA
    J Pediatr Hematol Oncol 27:11-4. 2005
    ..Although survivin mRNA was present at markedly greater levels than in normal kidney, none of the factors assayed independently or as a ratio was associated with stage of disease or risk for tumor recurrence in this group of tumors...
  25. ncbi request reprint Epigenetic differences between Wilms' tumours in white and east-Asian children
    Ryuji Fukuzawa
    Cancer Genetics Laboratory, Department of Biochemistry, University of Otago, Dunedin, New Zealand
    Lancet 363:446-51. 2004
    ..We investigated whether the difference in incidence of Wilms' tumour between children of east-Asian descent and white children is due to variations in proportion of tumours with loss of IGF2 imprinting (IGF2 LOI)...
  26. ncbi request reprint Breast-feeding and Wilms tumor: a report from the Children's Oncology Group
    Stephanie Saddlemire
    Department of Epidemiology, University of North Carolina, CB 7435, Chapel Hill, NC, 27599 7435, USA
    Cancer Causes Control 17:687-93. 2006
    ..We investigated the association between breast-feeding and Wilms tumor, a childhood kidney tumor...
  27. ncbi request reprint Pregnancy outcome after treatment for Wilms tumor: a report from the National Wilms Tumor Study Group
    Daniel M Green
    Department of Pediatrics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, USA
    J Clin Oncol 20:2506-13. 2002
    ....
  28. ncbi request reprint Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project
    Leslie L Robison
    Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota
    Med Pediatr Oncol 38:229-39. 2002
    ..To facilitate such research, a multi-institutional consortium established the Childhood Cancer Survivor Study (CCSS), a large, diverse, and well-characterized cohort of 5-year survivors of childhood and adolescent cancer...

Research Grants40

  1. LATE EFFECTS IN WILMS TUMOR SURVIVORS AND OFFSPRING
    Norman Breslow; Fiscal Year: 2000
    ..Collaboration with groups of molecular biologists, providing them national access to informative subgroups of patients, will speed their discoveries. ..
  2. STATISTICAL METHODS IN CANCER EPIDEMIOLOGY
    Norman Breslow; Fiscal Year: 2000
    ..The methods used to achieve these goals include mathematical and statistical analysis, computer simulation and application to important datasets collected by cancer epidemiologists and other public health scientists. ..
  3. LATE EFFECTS IN WILMS' TUMOR SURVIVORS AND OFFSPRING
    Norman Breslow; Fiscal Year: 1993
    ....
  4. STATISTICAL METHODS IN CANCER EPIDEMIOLOGY
    Norman Breslow; Fiscal Year: 2004
    ..The methods used to achieve these goals include mathematical and statistical analysis, computer simulation and application to important datasets collected by cancer epidemiologists and other public health scientists. ..
  5. Late Effects of Treatment in Wilms Tumor Survivors and Offspring
    Norman Breslow; Fiscal Year: 2009
    ..abstract_text> ..
  6. Late Effects of Treatment in Wilms Tumor Survivors and Offspring
    Norman Breslow; Fiscal Year: 2007
    ....
  7. LATE EFFECTS IN WILMS TUMOR SURVIVORS AND OFFSPRING
    Norman Breslow; Fiscal Year: 2006
    ..We will collaborate with molecular biologists by facilitating access to particularly informative subgroups of Wilms tumor patients. ..
  8. STATISTICAL METHODS IN CANCER EPIDEMIOLOGY
    Norman Breslow; Fiscal Year: 1991
    ..The new methods will be implemented on microcomputers and described in review articles and short courses so as to facilitate their transmission to research workers...
  9. STATISTICAL METHODS IN CANCER EPIDEMIOLOGY
    Norman Breslow; Fiscal Year: 1993
    ..The methods used to achieve these goals will include mathematical and statistical analysis, computer simulation and application of newly developed methods to important datasets collected by cancer epidemiologists...
  10. Late Effects of Treatment in Wilms Tumor Survivors and Offspring
    Norman E Breslow; Fiscal Year: 2011
    ..abstract_text> ..